Press release
Cancer Biomarkers Market: Advancements in Precision Medicine and Personalized Treatment Driving Growth | CAGR of 11.8% from 2020 to 2027
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/1443
Cancer biomarkers are measurable indicators that are used to diagnose, monitor, and predict the progression of cancer. These biomarkers can be proteins, genetic mutations, RNA molecules, or other molecules that are present in the blood, urine, or tissues of cancer patients.
There are several types of cancer biomarkers:
Diagnostic biomarkers: These biomarkers are used to detect the presence of cancer in an individual. For example, the prostate-specific antigen (PSA) is a diagnostic biomarker for prostate cancer.
Prognostic biomarkers: These biomarkers are used to predict the likely outcome of the disease, such as the probability of recurrence or metastasis. For example, the HER2/neu gene expression level is a prognostic biomarker for breast cancer.
Predictive biomarkers: These biomarkers are used to predict how an individual will respond to a particular treatment. For example, the presence of a mutation in the epidermal growth factor receptor (EGFR) gene is a predictive biomarker for response to certain targeted therapies in lung cancer.
Monitoring biomarkers: These biomarkers are used to monitor the progression of cancer and the response to treatment. For example, the level of carcinoembryonic antigen (CEA) in the blood is a monitoring biomarker for colorectal cancer.
Cancer biomarkers have the potential to revolutionize cancer diagnosis and treatment by enabling earlier detection, more accurate diagnosis, and personalized treatment plans. However, not all cancers have specific biomarkers, and some biomarkers may not be specific to cancer, which can lead to false positives or false negatives. Therefore, it is important to use biomarkers in conjunction with other diagnostic and clinical tools to make informed decisions about cancer diagnosis and treatment.
The growth of the global cancer biomarkers market is due to surge in adoption of cancer biomarkers primarily for prognostics and diagnostics applications across the globe.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐จ๐ซ ๐๐ก๐จ๐ซ๐ญ-๐ญ๐๐ซ๐ฆ ๐๐ง๐ ๐๐จ๐ง๐ -๐ญ๐๐ซ๐ฆ ๐๐ฆ๐ฉ๐๐๐ญ๐ฌ ๐จ๐ ๐๐๐๐๐-๐๐ ๐๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/1443
The cancer biomarkers market can be segmented based on several factors such as:
Type of biomarker: The market can be segmented based on the type of biomarker such as protein biomarkers, genetic biomarkers, epigenetic biomarkers, and others.
Application: The market can be segmented based on the application of the biomarkers such as diagnosis, prognosis, and treatment monitoring.
Cancer type: The market can be segmented based on the type of cancer such as breast cancer, lung cancer, colorectal cancer, prostate cancer, and others.
End-user: The market can be segmented based on end-users such as hospitals, diagnostic laboratories, research institutes, and others.
Region: The market can be segmented based on the geography such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
These segments can help companies to understand the needs and preferences of different customer groups and develop targeted marketing strategies. For example, companies can focus on developing biomarkers specific to a certain cancer type or target a particular end-user group such as hospitals or diagnostic laboratories.
North America to dominate in terms of revenue-
Based on geography, North America held the major share, garnering more than one-third of the global cancer biomarkers market, owing to strong focus on innovation and technological advancements in healthcare & diagnostics in the region. At the same time, Asia-Pacific is expected to manifest the fastest CAGR of 15.1% from 2020 to 2027. This is due to increase in prevalence of cancer, rise in patient awareness, and increase in disposable incomes in the province.
Frontrunners in the industry-
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Bristol-Myers Squibb Company
Exact Sciences Corporation
F.Hoffmann-La Roche Ltd.
Abbott Laboratories
Qiagen N.V.
Merck KGaA
PerkinElmer, Inc.
Siemens AG
๐๐ ๐๐๐๐๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ฅ๐ข๐๐ค @
https://www.alliedmarketresearch.com/request-for-customization/1443
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market: Advancements in Precision Medicine and Personalized Treatment Driving Growth | CAGR of 11.8% from 2020 to 2027 here
News-ID: 2945589 • Views: โฆ
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collectโฆ
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโฆ
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโฆ
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโฆ
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโฆ
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโฆ
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne โฆ
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theโฆ
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โฆ
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโฆ
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung โฆ
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forโฆ
